Medicines for Europe 20th Biosimilar Medicines Conference 2024

Generics and biosimilars Initiative

Building trust in cost-effective treatments

Sign up
eng / esp

Medicines for Europe 20th Biosimilar Medicines Conference 2024

Home/Conferences | Posted 22/03/2024 0

20th Biosimilar Medicines Conference
18–19 April 2024
Hilton Amsterdam Schiphol
The Netherlands

Maximising Value in Health with Biosimilar Policies

We closed the last edition in 2023 on a very positive note: biosimilar medicines have delivered huge access benefits for patients and a significant opportunity for healthcare systems to transform care pathways and deliver better patient outcomes. Stakeholders had underlined the undeniable role biosimilar medicines have played so far as a key pillar in patient access, treatment affordability, supply security and innovation.

As patient demand for biological medicines increases, and to keep pace with changes in the pharmaceutical and healthcare landscapes, but also beyond, we believe the next edition of the conference will provide a meaningful opportunity to jump start the multistakeholder policy process, ensuring the European policy framework and Global regulatory system secure more biosimilar medicines development and equitable access.

This 20th edition aims to provide a lively forum where important milestones are reached and acknowledged, the synergies facilitated, and future needs collectively reflected upon.

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth, and speed of the use of biosimilar medicines as a lever to untap their transformative value.

The various sessions will cover all relevant areas of healthcare and pharmaceutical policy, market access, scientific developments, regulatory, clinical, and patient experience.

As a participant in this event, you will:

interact openly with thought leaders in the field
engage in vibrant discussions with the full spectrum of healthcare stakeholders, policy makers and industry
deepen your knowledge on the latest regulatory and scientific hot topics
comprehend the impact that ongoing and future policy reforms will have on access to standards of care and competition in the biologics market
broaden your understanding of complex competition dynamics, market access policies and procurement features
factor in international regulatory developments when considering the longer-term perspective
access actionable takeaways and good practices from experts in their fields with relevance to your daily work